877773-17-6 Usage
Uses
Used in Pharmaceutical Research and Development:
6-Trifluoromethyl-1H-indazole-3-carboxylic acid methyl ester is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and properties contribute to the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 6-Trifluoromethyl-1H-indazole-3-carboxylic acid methyl ester is employed for its potential to enhance the pharmacological properties of drug candidates. Its incorporation into drug molecules can improve their efficacy, selectivity, and pharmacokinetic profiles, leading to the discovery of more effective therapeutic agents.
Used in Drug Discovery:
6-Trifluoromethyl-1H-indazole-3-carboxylic acid methyl ester plays a crucial role in drug discovery, where it is used to explore novel chemical spaces and identify potential drug candidates. Its unique properties allow researchers to design and synthesize new compounds with improved therapeutic potential and reduced side effects.
Used in Chemical Synthesis:
As a methyl ester derivative, 6-Trifluoromethyl-1H-indazole-3-carboxylic acid methyl ester is also used in various chemical synthesis processes. Its reactivity and functional groups make it a versatile building block for the preparation of a wide range of organic compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 877773-17-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,7,7,7 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 877773-17:
(8*8)+(7*7)+(6*7)+(5*7)+(4*7)+(3*3)+(2*1)+(1*7)=236
236 % 10 = 6
So 877773-17-6 is a valid CAS Registry Number.
InChI:InChI=1S/C10H7F3N2O2/c1-17-9(16)8-6-3-2-5(10(11,12)13)4-7(6)14-15-8/h2-4H,1H3,(H,14,15)
877773-17-6Relevant academic research and scientific papers
LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT
-
, (2011/02/24)
Fertility management can include: administering to the subject one or more doses of a compound according to Formula I so as to reduce fertility in the subject. Fertility management can also include administering an effective amount of the compound to: impair Sertoli cell function in a male subject; inhibit spermatogenesis in the subject; reduce testis weight in the subject; reduce ovary weight in a female subject; reduce serum progesterone in the female subject; impair ovarian follicle function in the female subject; causing reversible fertility in the subject. In order to return fertility, the method can include ceasing administration of the compound to the subject so as to return fertility in the subject. The compound can be administered for irreversibly sterilizing the subject.
Lonidamine analogues and their use in male contraception and cancer treatment
-
, (2008/06/13)
Novel compounds useful for inhibiting spermatogenesis and cancer treatment, and in particular as inhibitors of heat shock proteins and/or elongation factor 1 alpha.
